Stocks & Investing
Stocks and Investing
Stocks and Investing
Mon, December 18, 2023
[ Mon, Dec 18th 2023
] - WOPRAI
[ Mon, Dec 18th 2023
] - WOPRAI
[ Mon, Dec 18th 2023
] - WOPRAI
[ Mon, Dec 18th 2023
] - WOPRAI
[ Mon, Dec 18th 2023
] - WOPRAI
[ Mon, Dec 18th 2023
] - WOPRAI
[ Mon, Dec 18th 2023
] - WOPRAI
[ Mon, Dec 18th 2023
] - WOPRAI
[ Mon, Dec 18th 2023
] - WOPRAI
[ Mon, Dec 18th 2023
] - WOPRAI
[ Mon, Dec 18th 2023
] - WOPRAI
[ Mon, Dec 18th 2023
] - WOPRAI
[ Mon, Dec 18th 2023
] - WOPRAI
[ Mon, Dec 18th 2023
] - WOPRAI
[ Mon, Dec 18th 2023
] - WOPRAI
[ Mon, Dec 18th 2023
] - WOPRAI
[ Mon, Dec 18th 2023
] - WOPRAI
[ Mon, Dec 18th 2023
] - WOPRAI
[ Mon, Dec 18th 2023
] - WOPRAI
[ Mon, Dec 18th 2023
] - WOPRAI
[ Mon, Dec 18th 2023
] - WOPRAI
[ Mon, Dec 18th 2023
] - WOPRAI
[ Mon, Dec 18th 2023
] - WOPRAI
[ Mon, Dec 18th 2023
] - WOPRAI
[ Mon, Dec 18th 2023
] - WOPRAI
[ Mon, Dec 18th 2023
] - WOPRAI
[ Mon, Dec 18th 2023
] - WOPRAI
[ Mon, Dec 18th 2023
] - WOPRAI
[ Mon, Dec 18th 2023
] - WOPRAI
Kristen Kluska Reiterated (TSHA) at Buy and Held Target at $7 on, Dec 18th, 2023
Kristen Kluska of Cantor Fitzgerald, Reiterated "Taysha Gene Therapies, Inc." (TSHA) at Buy and Held Target at $7 on, Dec 18th, 2023.
Kristen has made no other calls on TSHA in the last 4 months.
There are 3 other peers that have a rating on TSHA. Out of the 3 peers that are also analyzing TSHA, 0 agree with Kristen's Rating of Hold.
These are the ratings of the 3 analyists that currently disagree with Kristen
- Gil Blum of "Needham" Reiterated at Strong Buy and Held Target at $5 on, Wednesday, September 20th, 2023
- Joon Lee of "Truist Securities" Maintained at Strong Buy with Decreased Target to $5 on, Wednesday, September 20th, 2023
- Whitney Ijem of "Canaccord Genuity" Maintained at Strong Buy with Decreased Target to $6 on, Wednesday, September 20th, 2023
